Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alendronate for Childhood Glucocorticoid-Associated Osteopenia
NCT00277251Phase 3Completed
- Sponsor
- Boston Children's Hospital
- Start
- Mar 2003
- Primary completion
- Jun 2006
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in osteoporosis and osteopenia comparing Alendronate with Standard of Care (2 arms). Primary endpoint: Mean change of individual AP spine bone mineral density at 18 months. Started Mar 2003; status: completed.
02
Drugs
alendronate
03
Conditions
osteoporosisosteopenia
Beyond the preview
Go deeper on NCT00277251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00277251.